July 2, 2022
  • Facebook
  • Twitter
  • LinkedIn

BJBMS Viewpoints

Science in plain words

  • Home
  • News
  • About
    • BJBMS Viewpoints
    • BJBMS Journal
  • BJBMS Journal
  • Reviews
  • pathology
  • microbiology
  • immunology
  • translational medicine
  • genetics
  • biochemistry
  • anatomy
  • molecular biology
  • clinical medicine
  • new methods
  • new medical entities
Latest posts
  • [ June 28, 2022 ] New Impact Factor (2021) for BJBMS is 3.759 News
  • [ June 27, 2022 ] PLCE1 gene might affect osteosarcoma immune status Author Summary
  • [ June 6, 2022 ] Serum microRNAs found to be promising diagnostic tools for papillary thyroid carcinoma Author Summary
  • [ June 3, 2022 ] Video summary: Efficacy of adjunctive photodynamic therapy in stage II – IV grade C Periodontitis Video Summary
  • [ June 1, 2022 ] The Reviewer of the Month for June 2022: Dr. Teodora Stankova Reviewer of the month
Homelipid levels

lipid levels

The statin and ezetimibe combination therapy in patients with high cardiovascular risk
Author Summary

The statin and ezetimibe combination therapy in patients with high cardiovascular risk

April 13, 2020 0

Cardiovascular diseases Cardiovascular diseases represent the most common cause of death worldwide. According to the World Health Organization (WHO), around 17.9 million deaths occur due to the cardiovascular diseases each year. Cardiovascular diseases are the […]

VIDEO SUMMARIES

BJBMS journal metrics

  • Impact Factor 2021 (JCR®): 3.76
  • CiteScore 2020 (Scopus): 5.2
  • Google Scholar Citations
  • Dimensions metrics

See more here…

BJBMS Newsletters

Subscribe to receive the latest content and news from BJBMS. Choose from our sections or themes of your interest.

Categories

  • Author Summary
  • News
  • Opinion
  • Reviewer of the month
  • Topics
  • Video Summary

Archives

TELL US

What matters the most when choosing the journal to submit your article?
Vote
Follow us on Facebook

Copyright (c) 2021 Association of Basic Medical Sciences of FBIH

 

Loading Comments...